ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,046Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 1269

$534K Total Retail Price of All Prescriptions

Rank: 129 out of 1269

275 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 275 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 275 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 10,975 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LEVOTHYROXINE SODIUM 483 473 1 4
FUROSEMIDE 425 425 2 5
LISINOPRIL 391 391 3 1
WARFARIN SODIUM 320 320 4 12
METOPROLOL TARTRATE 290 290 5 6
POLYETHYLENE GLYCOL 3350 263 263 6 50
GABAPENTIN 236 236 7 17
SIMVASTATIN 223 223 8 3
SERTRALINE HCL 212 212 9 23
ATENOLOL 209 209 10 14
QUETIAPINE FUMARATE 200 194 11 53
AMLODIPINE BESYLATE 191 191 12 2
MIRTAZAPINE 191 191 12 24
CITALOPRAM HBR 175 167 14 21
PANTOPRAZOLE SODIUM 165 165 15 18
OMEPRAZOLE 149 149 16 8
PRAVASTATIN SODIUM 148 148 17 11
DONEPEZIL HCL 146 146 18 22
KLOR-CON M20 142 142 19 60
TRAZODONE HCL 138 138 20 36
ATORVASTATIN CALCIUM 131 131 21 7
KLOR-CON M10 121 121 22 139
RANITIDINE HCL 117 117 23 27
CLOPIDOGREL 116 115 24 32
ALBUTEROL SULFATE 111 111 25 88
METOPROLOL SUCCINATE 108 108 26 13
HYDRALAZINE HCL 108 108 26 48
POTASSIUM CHLORIDE 106 106 28 26
LOSARTAN POTASSIUM 99 99 29 15
TAMSULOSIN HCL 97 97 30 31
FLUTICASONE PROPIONATE 96 96 31 40
HYDROCHLOROTHIAZIDE 94 94 32 10
PLAVIX 91 91 33 47
ADVAIR DISKUS 90 90 34 46
NAMENDA 89 89 35 38
ALLOPURINOL 88 88 36 49
METFORMIN HCL 87 76 37 9
PREDNISONE 85 85 38 45
TRAMADOL HCL 80 80 39 16
LEVOFLOXACIN 79 79 40 75
CARVEDILOL 77 77 41 29
TRIAMTERENE-HCTZ 77 77 41 69
CARBIDOPA-LEVODOPA 74 74 43 78
KLOR-CON 10 73 73 44 122
CIPROFLOXACIN HCL 72 72 45 66
CLONIDINE 71 71 46 270
SPIRIVA 68 67 47 64
SEROQUEL 68 61 47 104
GLIPIZIDE 67 67 49 37
DILTIAZEM 24HR CD 66 66 50 146
RISPERIDONE 64 64 51 43
ESCITALOPRAM OXALATE 64 64 51 58
DIOVAN 62 51 53 35
DANTROLENE SODIUM 62 62 53 352
IPRATROPIUM-ALBUTEROL 60 60 55 86
DIGOXIN 60 60 55 62
LIDODERM 60 60 55 56
AZITHROMYCIN 58 58 58 42
LANTUS 54 54 59 39
FINASTERIDE 53 53 60 112
SANTYL 51 51 61 101
FLUOXETINE HCL 51 49 61 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.